Identification of a novel coronavirus and the landscape of prevention and control of emerging infectious diseases

Since December 2019, there has been widespread concern over an unexplained pneumonia epidemic in Wuhan. Less than a month later, the expert team has identified the etiology, a novel coronavirus, which has won a "golden window" for effectively preventing the spread of the emerging infectious diseases. The prompt response of Chinese researchers to emerging infectious diseases has been recognized and appreciated by the World Health Organization, and reflects that the substantially improved ability to identify emerging infectious diseases. However, the strength of the current infectious disease discipline in China has yet to be further strengthened to meet the needs of China's public health development and the challenges of infectious diseases. Faced with urban aging and the spread of drug-resistant bacterial infections, as well as the increase in imported diseases and the uncontrollable risks of unknown infectious diseases, the future demand for infectious disease prevention and control systems in China is diverse, open, and flexible, including but It is not limited to the prevention and control of communicable diseases, diagnosis and treatment of bacterial and fungi infections, nosocomial infection control, and the use of antibiotic-resistant antibacterial drugs. Infectious disease professionals take on important tasks and responsibilities to protect the "Healthy China" strategy. Key words: SARS-CoV-2 infection; New infectious diseases; Identification of virus